Evaluate the Frequency of Fatigue After Cerebral Infarction

Centre Hospitalier Universitaire Dijon126 enrolled

Overview

Cerebral infarction is a type of stroke that can lead to sometimes disabling sequelae. Among these sequelae, fatigue is frequently reported by patients. It is therefore important for doctors to understand why patients suffer from fatigue after cerebral infarction and to determine whether treatments given for the cerebral infarction may have an impact on this fatigue. The aim of this research was to study the frequency of fatigue after cerebral infarction, the associated factors, in particular the impact of treatments administered in the acute phase.

Study Type

OBSERVATIONAL

Enrollment

126

Conditions

Symptomatic Cerebral Infarction

Interventions

FSS: Fatigue Severity ScaleOTHER

Fatigue scale with 9 items rated from 1 to 7, assessing physical fatigue, fatigue in the psychosocial environment and fatigue in general (3 items in each category).

Neuropsychological evaluation batteryOTHER

A standardized French neuropsychological battery for the cognitive evaluation of stroke patients.

Other functional scoresOTHER

Rankin Score, Instrumental Activities of Daily Living (IADL) Score, Rivermead Mobility Index (RMI) scale, Hospital Anxiety Depression scale (HAD) scale for depression / anxiety, Stroke Specific Quality of Life scale for quality of life, Quality Index of Pittsburgh Sleep (PSQI), Vertical Analog Visual Scale for Pain and Vertical Digital Visual Scale

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Patients presenting recent symptomatic cerebral infarction (\< 1 week) defined according to World Health Organization (WHO) criteria and hospitalised at the Stroke Unit in Dijon University. * Patients aged 18 years or older. * Patients who have been informed about the study, or their person of trust for patients unable to express their consent. Exclusion Criteria: * Patients (or their person of trust) who refuse to participate in the study. * Subjects in custody. * Patients presenting prior co-morbidity as a cause of significant fatigue in the opinion of the investigator * Patients with dementia or aphasia before the stroke * Patients (or their person of trust) who may be difficult to contact by telephone during the follow-up.

Locations (1)

CHU Dijon Bourgogne

Dijon, France

Outcomes

Primary Outcomes

Fatigue evaluated using the Fatigue Severity Scale (FSS)

Time frame: 6 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.